Demographic and disease characteristics of multiple sclerosis in the Southwest Region of Saudi Arabia

References

1. ↵
   1. Browne P,
   2. Chandraratna D,
   3. Angood C,
   4. Tremlett H,
   5. Baker C,
   6. Taylor BV,
   7. et al.

   (2014) Atlas of Multiple Sclerosis 2013:A growing global problem with widespread inequity. Neurology 83, 1022–1024.
2. ↵
   1. Sahraian MA,
   2. Sahebkar M,
   3. Dehghani R,
   4. Derakhshan-Jazari M,
   5. Kazami-Moghaddam V,
   6. Kouchaki E

   (2017) Multiple sclerosis-A disease on a dramatically rising trend in Iran:Review of possible reasons. Iran J Neurol 16, 34–40.
3. ↵
   1. Deleu D,
   2. Mir D,
   3. Al Tabouki A,
   4. Mesraoua R,
   5. Mesraoua B,
   6. Akhtar N,
   7. et al.

   (2013) Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler 19, 816–819.
4. ↵
   1. Alroughani R,
   2. Ahmed SF,
   3. Behbahani R,
   4. Khan R,
   5. Thussu A,
   6. Alexander KJ,
   7. et al.

   (2014) Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Mult Scler 20, 543–547.
5. ↵
   1. Nasr Z,
   2. Etemadifar M,
   3. Khalili B

   (2014) Epidemiology of multiple sclerosis in the Middle East:A systematic review and meta analysis. Mult Scler Relat Disord 3, 744.
6. ↵
   1. Heydarpour P,
   2. Khoshkish S,
   3. Abtahi S,
   4. Moradi-Lakeh M,
   5. Sahraian MA

   (2015) Multiple Sclerosis Epidemiology in Middle East and North Africa:A Systematic Review and Meta-Analysis. Neuroepidemiology 44, 232–244.
7. ↵
   1. Alroughani R,
   2. Boyko A

   (2018) Pediatric multiple sclerosis:a review. BMC Neurol 18, 27.
8. ↵
   1. Narula S

   (2016) Pediatric multiple sclerosis:updates in epidemiology, clinical features and management. Neurodegener Dis Manag 6, 3–7.
9. ↵
   1. Koriem KMK

   (2016) Multiple sclerosis:New insights and trends. Asian Pac J Trop Biomed 6, 429–440.
10. ↵
    1. Thompson AJ,
    2. Banwell BL,
    3. Barkhof F,
    4. Carroll WM,
    5. Coetzee T,
    6. Comi G,
    7. et al.

    (2018) Diagnosis of multiple sclerosis:2017 revisions of the McDonald criteria. Lancet Neurol 17, 162–173.
11. ↵
    1. Jeffery DR

    (2013) Recent advances in treating multiple sclerosis:efficacy, risks and place in therapy. Ther Adv Chronic Dis 4, 45–51.
12. ↵
    1. Yaqub BA,
    2. Daif AK

    (1988) Multiple sclerosis in Saudi Arabia. Neurology 38, 621–623.
13. ↵
    1. Al-Shammri SN,
    2. Hanna MG,
    3. Chattopadhyay A,
    4. Akanji AO

    (2015) Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait:A Case - Control Study. PLoS One 10, 0132106.
14. 1. Gustavsen MW,
    2. Page CM,
    3. Moen SM,
    4. Bjølgerud A,
    5. Berg-Hansen P,
    6. Nygaard GO,
    7. et al.

    (2014) Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study. BMC Neurol 14, 196.
15. 1. Poorolajal J,
    2. Mazdeh M,
    3. Saatchi M,
    4. Talebi Ghane E,
    5. Biderafsh A,
    6. Lotfi B,
    7. et al.

    (2015) Multiple Sclerosis Associated Risk Factors:A Case-Control Study. Iran J Public Health 44, 1498–1505.
16. ↵
    1. Al-Afasy HH,
    2. Al-Obaidan MA,
    3. Al-Ansari YA,
    4. Al-Yatama SA,
    5. Al-Rukaibi MS,
    6. Makki NI,
    7. et al.

    (2013) Risk factors for multiple sclerosis in Kuwait:a population-based case-control study. Neuroepidemiology 40, 30–35.
17. ↵
    1. Bohlega S,
    2. Inshasi J,
    3. Al Tahan AR,
    4. Madani AB,
    5. Qahtani H,
    6. Rieckmann P

    (2013) Multiple sclerosis in the Arabian Gulf countries:a consensus statement. J Neurol 260, 2959–2963.
18. ↵
    1. General Authority for Statistics

    (2016) (Demography Survey, Kingdom of Saudi Arabia) Available from: https://www.stats.gov.sa/sites/default/files/en-demographic-research-2016_2.pdf. Accessed on April 15, 2018.
19. ↵
    1. Mohammed EM

    (2016) Multiple sclerosis is prominent in the Gulf states. Pathogenesis 3, 19–38.